share_log

D. Boral Capital Initiates Coverage On MediciNova With Buy Rating, Announces Price Target of $9

D. Boral Capital Initiates Coverage On MediciNova With Buy Rating, Announces Price Target of $9

D. Boral Capital對美第奇新星生物技術啓動覆蓋,給予買入評級,並宣佈價格目標爲9美元。
Benzinga ·  12/02 21:30  · 評級/大行評級

D. Boral Capital analyst Jason Kolbert initiates coverage on MediciNova (NASDAQ:MNOV) with a Buy rating and announces Price Target of $9.

D. Boral Capital 分析師 Jason Kolbert 對美第奇新星生物技術(納斯達克:MNOV)進行覆蓋,給予買入評級,並宣佈價格目標爲9美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論